• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSS2200006 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(1) New Drug Application 2022-01-19 Shanghai Shengdi Pharmaceutical Co Ltd;Suzhou Suncadia Biopharmaceuticals Co Ltd view
CXSL2200099 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(1) New Drug Application 2022-02-21 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2200199 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(1) New Drug Application 2022-05-07 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2200198 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(1) New Drug Application 2022-05-07 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2200555 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(1) New Drug Application 2022-11-02 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2300096 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(1) New Drug Application 2023-02-08 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2300324 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2023-05-10 Shanghai Shengdi Pharmaceutical Co Ltd view
CYSB2300098 阿得贝利单抗注射液 Adebrelimab Injection Biological Products Supplementary Application 2023-05-18 Shanghai Shengdi Pharmaceutical Co Ltd;Suzhou Suncadia Biopharmaceuticals Co Ltd view
CXSL2300581 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2023-08-30 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2300618 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2023-09-13 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2300657 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2023-09-26 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2300693 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2023-10-13 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2300746 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2023-11-01 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2300794 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2023-11-20 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2300824 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2023-11-30 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2300834 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2023-12-01 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2300838 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2023-12-05 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400026 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-01-12 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400041 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-01-19 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400048 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-01-22 Shanghai Shengdi Pharmaceutical Co Ltd view